Concepedia

Kam Fai Tse

KF

2

Publications

268

Citations

2

H-Index

2006

Active since

Affiliations

Sepragen Corporation (United States)(Current)

Kam Fai Tse is an author at Sepragen Corporation (United States) specializing in cancer cell biology, oncology, and tumor biology.

Top concepts

MedicineOncologyImmunologyCell BiologyImmunotherapyTumor BiologyCancer ResearchCancer Cell Biology

Publications per year

2006–2007

2

Publications

2

CR011, a fully human monoclonal antibody-auristatin E conjugate, for the treatment of melanoma.

Kam Fai Tse, Michael Jeffers, Vincent A. Pollack et al. · Clinical Cancer Research · 2006 · 186 citations

Treatment parameters modulating regression of human melanoma xenografts by an antibody–drug conjugate (CR011-vcMMAE) targeting GPNMB

Vincent A. Pollack, Enrique Álvarez, Kam Fai Tse et al. · Cancer Chemotherapy and Pharmacology · 2007 · 82 citations

Antibody–drug Conjugate, Tumor Biology, Drug Targeting +12

Rows per page

1–2 of 2